TY - JOUR
T1 - Optimal Design of Paired Built Environment Interventions for Control of MDROs in Acute Care and Community Hospitals
AU - Squire, Marietta M.
AU - Sessel, Gareth K.
AU - Lin, Gary
AU - Squire, Edward N.
AU - Igusa, Takeru
N1 - Funding Information:
The Army Public Health Center provided the infection cost data, over 6 years, obtained from two databases. The authors would like to thank Dr. Lanna Forrest, Dr. John Ambrose, Dawn Eslinger, and Dawn Malozi for their feedback and collaboration. The Walter Reed Army Institute of Research Multidrug-Resistant Organism Repository and Surveillance Network provided the 8-year period, original, longitudinal, infectious disease data. The authors would like to thank Major Anthony Jones, Lieutenant Colonel Jason W. Bennett, Dr. Patrick McGann, and the MRSN staff for their feedback and collaboration throughout the investigation. The Army Medical Command provided deidentified admission data. Thank-you to Dr. Stephanie Taylor for her insight and perspective. We would also like to thank the Medical Center of Excellence for their feedback. Thanks to Alexandros Moissiadis for his assistance and work in the initial model development phase. The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded by the U.S. Army Medical Command, U.S. Army Medical Department Center and Schools and Johns Hopkins University. G.L. was supported by the Centers for Disease Control and Prevention MInD-Healthcare Program (grant number 1U01CK000536).
Funding Information:
The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded by the U.S. Army Medical Command, U.S. Army Medical Department Center and Schools and Johns Hopkins University. G.L. was supported by the Centers for Disease Control and Prevention MInD-Healthcare Program (grant number 1U01CK000536).
Publisher Copyright:
© The Author(s) 2020.
PY - 2021/4
Y1 - 2021/4
N2 - Objectives: Our goal was to optimize infection control of paired environmental control interventions within hospitals to reduce methicillin-resistant Staphylococcus aureus (MRSA), carbapenem-resistant Enterobacteriaceae (CRE), and vancomycin-resistant Enterococci (VRE). Background: The most widely used infection control interventions are deployment of handwashing (HW) stations, control of relative humidity (RH), and negative pressure (NP) treatment rooms. Direct costs of multidrug-resistant organism (MDRO) infections are typically not included in the design of such interventions. Methods: We examined the effectiveness of pairing HW with RH and HW with NP. We used the following three data sets: A meta-analysis of progression rates from uncolonized to colonized to infected, 6 years of MDRO treatment costs from 400 hospitals, and 8 years of MDRO incidence rates at nine army hospitals. We used these data as inputs into an Infection De-Escalation Model with varying budgets to obtain optimal intervention designs. We then computed the infection and prevention rates and cost savings resulting from these designs. Results: The average direct cost of an MDRO infection was $3,289, $1,535, and $1,067 for MRSA, CRE, and VRE. The mean annual incidence rates per facility were 0.39%, 0.034%, and 0.011% for MRSA, CRE, and VRE. After applying the cost-minimizing intervention pair to each scenario, the percentage reductions in infections (and annual direct cost savings) in large, community, and small acute care hospitals were 69% ($1.5 million), 73% ($631K), 60% ($118K) for MRSA, 52% ($460.5K), 58% ($203K), 50% ($37K) for CRE, and 0%, 0%, and 50% ($12.8K) for VRE. Conclusion: The application of this Infection De-Escalation Model can guide cost-effective decision making in hospital built environment design to improve control of MDRO infections.
AB - Objectives: Our goal was to optimize infection control of paired environmental control interventions within hospitals to reduce methicillin-resistant Staphylococcus aureus (MRSA), carbapenem-resistant Enterobacteriaceae (CRE), and vancomycin-resistant Enterococci (VRE). Background: The most widely used infection control interventions are deployment of handwashing (HW) stations, control of relative humidity (RH), and negative pressure (NP) treatment rooms. Direct costs of multidrug-resistant organism (MDRO) infections are typically not included in the design of such interventions. Methods: We examined the effectiveness of pairing HW with RH and HW with NP. We used the following three data sets: A meta-analysis of progression rates from uncolonized to colonized to infected, 6 years of MDRO treatment costs from 400 hospitals, and 8 years of MDRO incidence rates at nine army hospitals. We used these data as inputs into an Infection De-Escalation Model with varying budgets to obtain optimal intervention designs. We then computed the infection and prevention rates and cost savings resulting from these designs. Results: The average direct cost of an MDRO infection was $3,289, $1,535, and $1,067 for MRSA, CRE, and VRE. The mean annual incidence rates per facility were 0.39%, 0.034%, and 0.011% for MRSA, CRE, and VRE. After applying the cost-minimizing intervention pair to each scenario, the percentage reductions in infections (and annual direct cost savings) in large, community, and small acute care hospitals were 69% ($1.5 million), 73% ($631K), 60% ($118K) for MRSA, 52% ($460.5K), 58% ($203K), 50% ($37K) for CRE, and 0%, 0%, and 50% ($12.8K) for VRE. Conclusion: The application of this Infection De-Escalation Model can guide cost-effective decision making in hospital built environment design to improve control of MDRO infections.
KW - CRE
KW - MRSA
KW - VRE
KW - admissions
KW - built environment
KW - cleaning
KW - colonized
KW - cost savings
KW - direct cost
KW - handwashing
KW - healthcare-associated infection
KW - hospital
KW - infection control
KW - multidrug-resistant organism
KW - patient safety
KW - quality improvement
UR - http://www.scopus.com/inward/record.url?scp=85098620540&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85098620540&partnerID=8YFLogxK
U2 - 10.1177/1937586720976585
DO - 10.1177/1937586720976585
M3 - Article
C2 - 33375862
AN - SCOPUS:85098620540
SN - 1937-5867
VL - 14
SP - 109
EP - 129
JO - Health Environments Research and Design Journal
JF - Health Environments Research and Design Journal
IS - 2
ER -